Hans Hoffmann

11.4k citations
146 papers · 5.3k indexed · 1 hit paper · h-index 40

Impact in

    • Lung Cancer Diagnosis and Treatment
    • Lung Cancer Treatments and Mutations
    • Pleural and Pulmonary Diseases
    • Medical Imaging and Pathology Studies
    • Occupational and environmental lung diseases
  • Oncology top 1%
    • Lung Cancer Research Studies

Papers in

    • Lung Cancer Diagnosis and Treatment 58
    • Lung Cancer Treatments and Mutations 47
    • Pleural and Pulmonary Diseases 22
    • Medical Imaging and Pathology Studies 11
    • Occupational and environmental lung diseases 10
    • Lung Cancer Research Studies 18
    • Cancer Immunotherapy and Biomarkers 11

Hans Hoffmann

133 papers receiving 5.2k citations

Hit Papers

The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival 2012 · 542 citations
5422012202620162021100200300400500

Peers

Hans Hoffmann
Comparison fields: 5 of 118
  • Pulmonary and Respiratory Medicine 3.5k
  • Oncology 2.0k
  • Hepatology 461
  • Cancer Research 497
  • Radiology, Nuclear Medicine and Imaging 729
Replace Hendrik Dienemann with:
Hendrik Dienemann Germany
Michael Lanuti United States
Daniel J. Boffa United States
Masahiko Higashiyama Japan
Marco Alloisio Italy
Wilfried Eberhardt Germany
Reza J. Mehran United States
Michelle S. Ginsberg United States
Lunxu Liu China
Norihiko Ikeda Japan
Hans Hoffmann relative to Hendrik Dienemann Germany Hendrik Dienemann's profile →
Citations per field
00.5×1.5×
Hendrik Dienemann · 1×
Citations per year

Countries citing papers authored by Hans Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Hans Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Hoffmann more than expected).

Fields of papers citing papers by Hans Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Hoffmann. The network helps show where Hans Hoffmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Hans Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hans Hoffmann Line = papers co-authored together Hans Hoffmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival
Hit paper breakdown →
2012542
2 2007420
3 2012246
4 2003193
5 2002176
6 2008152
7 2018131
8 2006115
9 2007105
10 201097
11 201296
12 201293
13 200792
14 200689
15 201189
16 201289
17 200983
18 201179
19
Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.
201574
20 201071

About Hans Hoffmann

Hans Hoffmann is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Microbiology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 146 papers that have together received 5.3k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (58 papers), Lung Cancer Treatments and Mutations (47 papers), Pleural and Pulmonary Diseases (22 papers), Lung Cancer Research Studies (18 papers), Radiomics and Machine Learning in Medical Imaging (13 papers), Cancer Immunotherapy and Biomarkers (11 papers), Medical Imaging and Pathology Studies (11 papers) and Occupational and environmental lung diseases (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.5k citations), Oncology (2.0k citations), Hepatology (461 citations), Cancer Research (497 citations) and Radiology, Nuclear Medicine and Imaging (729 citations). Hans Hoffmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Hendrik Dienemann, Joachim Pfannschmidt, Thomas Muley, Arne Warth, Philipp A. Schnabel, Felix Herth, Michael Meister, Peter Schirmacher, Michael Thomas and Wilko Weichert. Their work appears in journals such as Lung Cancer, Journal of Thoracic Oncology, The Annals of Thoracic Surgery, BMC Cancer and European Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026